Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,298.00    -20.00 (-0.14%)
Bid:
14,316.00
Ask:
14,318.00
Spread: 2.00 (0.014%)
Market Cap: £221.74b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

US will still pay at least twice as much after negotiating drug prices
3 Sep 2024

US will still pay at least twice as much after negotiating drug prices

U.S. pays higher drug prices, gets priority access *

TOP NEWS: AstraZeneca asthma drug Fasenra gets approval in China
20 Aug 2024

TOP NEWS: AstraZeneca asthma drug Fasenra gets approval in China

(Alliance News) - AstraZeneca PLC on Tuesday announced that China's National Medical Products Association has approved benralizumab to treat patients ...

LONDON BRIEFING: Gran Tierra makes GBP174 million offer for i3 Energy
20 Aug 2024

LONDON BRIEFING: Gran Tierra makes GBP174 million offer for i3 Energy

(Alliance News) - Stocks in London are called to open lower on Tuesday, as investors look ahead to a key inflation reading from the eurozone.

AstraZeneca and Daiichi Sankyo gets US and European nods for Enhertu
19 Aug 2024

AstraZeneca and Daiichi Sankyo gets US and European nods for Enhertu

(Alliance News) - Daiichi Sankyo Co Ltd on Monday announced positive updates for Enhertu, with the cancer drug receiving support from US and European ...

London close: Stocks slip on relatively quiet Friday
16 Aug 2024

London close: Stocks slip on relatively quiet Friday

(Sharecast News) - London's stock markets closed lower on Friday, weighed down by a stronger pound and mixed investor sentiment following the release ...

AstraZeneca's Infinzi gets US approval for treatment of lung cancer
16 Aug 2024

AstraZeneca's Infinzi gets US approval for treatment of lung cancer

(Alliance News) - AstraZeneca PLC on Friday said Imfinzi has been approved in the US for the treatment of resectable non-small cell lung cancer before...

AstraZeneca's Imfinzi gets fresh approval in the US
16 Aug 2024

AstraZeneca's Imfinzi gets fresh approval in the US

(Sharecast News) - AstraZeneca announced on Friday that the US Food and Drug Administration (FDA) has approved its drug durvalumab, branded Imfinzi, f...